Navigation Links
Resverlogix's Lead Drug Featured in Key Scientific Publication
Date:7/18/2008

RVX-208 is the only Apo-Al/HDL drug to be highlighted

TSX Exchange Symbol: RVX

CALGARY, July 18 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce that Resverlogix's lead drug is featured prominently in an article titled "Emerging Antidyslipidemic Drugs", which appears in the current edition of Expert Opinion of Emerging Drugs, a well respected scientific journal for the pharmaceutical industry. The article written by Drs.' Pollex, Joy and Hegele provides an overview of current and upcoming dyslipidemic drugs.

"To be the only ApoA-l/HDL drug highlighted in an esteemed journal such as Expert Opinion of Emerging Drugs speaks volumes as to the excitement felt in the scientific community for our lead drug RVX-208," stated Donald McCaffrey, President and CEO of Resverlogix. "The data provided to the authors was our preclinical data. The Phase 1a data which we recently announced illustrated very similar trending as the African Green Monkey data of increased ApoA-I production and HDL functionality, thus our enthusiasm continues to build as we head into our Phase 1b/2a trial later this year."

RVX-208 is a first-in-class small molecule that facilitates endogenous ApoA-I production. It is positioned as one of the most promising emerging drugs in the treatment of atherosclerosis, the largest medical market in the world with a critical unmet need. To the Company's knowledge RVX-208 is the only novel small molecule that is specifically designed to increase ApoA-I production. Consequently this raises functional HDL levels which in turn enhance reverse cholesterol transport, atherosclerosis regression and ultimately reduction of major adverse cardiovascular events (MACE).

About Resverlogix Corp.

Resverlogix Corp. is a leading biotechnology company engaged in the development of novel therapies for important global medical markets with significant unmet needs. The NexVas(TM) pr
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. lifesDHA(TM) Featured in New Ricos(R) Cheese Sauce
2. Boydens Summit Practice Featured in the September Issue of New Jersey Business Magazine
3. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
4. Synvista Therapeutics to be Featured on Wallst.net
5. Astex Drug Candidates to be Featured at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
6. NanoLogixs Hydrogen-From-Waste Technology at Welchs Foods Featured on Environmental Radio Program
7. Marteks lifesDHA(TM) Now Featured in Two New Flavors of Rachels(R) Wickedly Delicious Yogurt from WhiteWave Foods
8. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
9. CT Laser Mammography Technology to be Featured at Interdisciplinary Breast Cancer Conference
10. Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race
11. CT Laser Mammography Technology to be Featured at European Congress of Radiology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...5/PRNewswire/--Formanybusinesses,2009hasbeenapainf...stestgrowingnetworkofexpertphysiciansspecializinge...es has grownthenumberof physiciansinitsnetwork ...ogresstoaddmorephysician-ownedcenters,includingone...ar ,BodyLogicMDhasopened13newbioidenticalhormonesp...
(Date:11/24/2009)...an . , Whether it,s CD packaging, containers...cy Identification) are increasingly finding their ...abel objects or goods and identify them automatica...n read and process the data contained in the label...ction conditions of up to 100 degrees Celsius. But...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--DowAgroSciencesCanadaa...divisionofThompsonsLimitedofBlenheim,Ontario.Thead...s,currentseedsbusinessasthecompanyanticipatesthein...encesHerbicideTolerantTraitTechnologyincornin2012...., "Thisacquisitionbringstogethertwostrongprogres...
(Date:11/24/2009)...ia/--NODPharmaceuticalsInc.announced,theUSPatent&a...ionfor,itsnano-particleoraldeliveryorNODtechnology...incorporatepeptidesor,proteinsintobio-adhesivenano...inisteredasinjections.NODtechnologyisaplatformtech...chasinsulin,interferon,growthhormone,exenatide,he...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Intelligence inside metal components 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...ting meeting took place this past week at the Univ...hicago Technology Forum. The focus of the meeting ...who have been intimately involved in the last annu...to what we might expect or should prepare for when...hicago in April, 2006. , ,Some Chicagoans have lik...
... has launched a pilot program for one Fitchburg ne...as high as 10 megabits per secondseveral times hig...tly availablein order to gauge customer usage and ..., ,With whats going on with the Internet today, we...ster speeds, said TDS marketing manager Michele Fa...
...enome Atlas is intented to be for cancers what the...ill let scientists better distinguish different ty...treatments that are more likely to work on patient...l treatment plans. , ,National agencies are starti...ral money over the next three years to study a sam...
Other Biology Technology:The legacy of BIO 2006, what it will be and how we need to plan for it now 2The legacy of BIO 2006, what it will be and how we need to plan for it now 3The legacy of BIO 2006, what it will be and how we need to plan for it now 4The legacy of BIO 2006, what it will be and how we need to plan for it now 5The legacy of BIO 2006, what it will be and how we need to plan for it now 6TDS tries bringing fiber to homes in Fitchburg for faster Internet service 2TDS tries bringing fiber to homes in Fitchburg for faster Internet service 3
(Date:11/23/2009)... TORONTO, November 23, 2009 - The time of day matt...g to a new paper produced by a research team led b...o Scarborough,s vice-principal for research and co...logy at the St. George campus. , Capitalizing ... poplar tree, the research team examined how popla...
(Date:11/23/2009)...armington, CT Current research suggests that a co...ase. The related report by Nichols et al, "Unique...New Class of TLR2 Ligands Capable of Enhancing Aut...The American Journal of Pathology . , Multiple ...attacks the brain and spinal cord, affects nearly ...
(Date:11/23/2009)...IVERMORE, Calif. - By producing some of the highes...al surfaces, scientists have a deeper understandin... This research may lead to a new treatment for kid...hich appears in the Nov. 23 online edition of the ...iences , explores how peptides interact with miner...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Two Powerful Companies One Powerhouse in Protection 55790 1Two Powerful Companies One Powerhouse in Protection 55790 2Stemedica Achieves Major Milestone Company Receives License to Manufacture Clinical Grade Stem Cells 4924 1Stemedica Achieves Major Milestone Company Receives License to Manufacture Clinical Grade Stem Cells 4924 2Shifting baselines confound river restoration 9746 1Shifting baselines confound river restoration 9746 2
...searchers from the University of Alberta, the Yerk...rsity and the Emory Transplant Center has successf...ne islet cells into monkeys, a procedure the resea...ution to the critical supply problem in clinical i... A and Emory, along with recent work at the Univer...
...at the University of Pennsylvania School of Medici...ed Vpr destroys the host cell,s ability to survive...ps an important enzyme from activating the cell,s ...derstanding of Vpr HIV pathogenesis and imply new ... such as rheumatoid arthritis, and possibly sepsis...
...ticular cartilage (cartilage covering the ends of ...s due to injury or illness, and can lead to degene...ches to repair this articular cartilage have achie...hod to fully restore this type of injured cartilag...erapeutic proteins to the injured site is a promis...
Other Biology News:Diabetes researchers pioneer islet cell xenotransplantation in primate studies 2HIV accessory protein disables host immunity via receptor-protein intermediary 2Stem cells from muscles can repair cartilage 2Stem cells from muscles can repair cartilage 3
...l to BRF2 Immunogen Synthetic peptide: QAARQAATS...-419 of Human BRF2. Reactivity / Specificity Cro...ies. Background Information BRF2 is one of the m...iption factor complex required for transcription o...
Kinase Buffer (10X) from Cell Signaling Technology
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Biology Products: